We established tumour self-seeding models with or without shRNA or inhibitor treatment and found that both IL-6 shRNA and cryptotanshinone inhibited the seeding of RFP-labelled CTCs into primary tumours (Figures 5c–5e). Here, IL6 is linked to neoplasm.